Showing results (341-350 of 798) with videos related to
Sort By:
Pageof 80
Chest|March 14, 2000
Adult presentation of agenesis of the hemidiaphragmJ J Sheehan, S R Kearns, D A McNamara, et al.Oral Oncology|February 13, 2001
Meat, fat and risk of laryngeal cancer: a case-control study in UruguayF Oreggia, E De Stefani, P Boffetta, et al.International Journal for Parasitology. Drugs and Drug Resistance|March 18, 2020
Drug resistance in liver flukesI Fairweather, G P Brennan, R E B Hanna, et al.Annals of Surgery|August 1, 1990
Long-term follow-up of brachial artery ligation in childrenK P Lally, C E Foster, W J Chwals, et al.FEMS Microbiology Ecology|November 9, 2012
Insights into the low-temperature adaptation and nutritional flexibility of a soil-persistent Escherichia coliFiona P Brennan, Jim Grant, Catherine H Botting, et al.Molecular and Biochemical Parasitology|September 18, 2012
An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populationsRichard Wilkinson, Christopher J Law, Elizabeth M Hoey, et al.British Journal of Cancer|June 11, 2008
Anthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case-control studyA Mathew, V Gajalakshmi, B Rajan, et al.Preventive Medicine Reports|March 24, 2022
Obstetrician/gynecologists' HPV vaccination recommendations among women and girls 26 and youngerLuke P Brennan, Natalia M Rodriguez, Katharine J Head, et al.Human Pathology|February 24, 2000
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosisT T Lah, E Kalman, D Najjar, et al.Parasitology Research|May 5, 2011
Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazoleEmma Toner, Gerard P Brennan, Robert E B Hanna, et al.Pageof 80